Market Overview

Edwards Lifesciences Confirms Appeals Court Ruling of Medtronic's Willful Infringement of Transcatheter Valve Patent

Share:
Related EW
Earnings Scheduled For July 28, 2015
5 NYSE Healthcare Stocks With The Highest ROI
Abiomed Close To New Buy Point Ahead Of Q1 Earnings (Investor's Business Daily)
Related MDT
Benzinga's Top Upgrades
Medtronic To Acquire RF Surgical Systems
United Therapeutics Misses on Q2 Earnings & Revenues - Analyst Blog (Zacks)

Edwards Lifesciences Corporation (NYSE: EW) announced that the U.S. Court of Appeals for the Federal Circuit today affirmed an April 2010 federal jury decision that Medtronic (NYSE: MDT) CoreValve LLC is willfully infringing Edwards' U.S. Andersen transcatheter heart valve patent. The Appeals Court also ordered the trial court to reconsider Edwards' request for a permanent injunction that would prohibit the manufacture and sale of the CoreValve System in the United States. In addition, the Court affirmed the validity of this patent and the federal jury's verdict awarding an initial payment of $74 million in damages to Edwards, which covers infringement through early 2010.

Posted-In: News Legal

 

Related Articles (EW + MDT)

Get Benzinga's Newsletters